1. Home
  2. GAUZ vs GNFT Comparison

GAUZ vs GNFT Comparison

Compare GAUZ & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • GNFT
  • Stock Information
  • Founded
  • GAUZ 2009
  • GNFT 1999
  • Country
  • GAUZ Israel
  • GNFT France
  • Employees
  • GAUZ N/A
  • GNFT N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GAUZ Miscellaneous
  • GNFT Health Care
  • Exchange
  • GAUZ Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • GAUZ 152.3M
  • GNFT 186.3M
  • IPO Year
  • GAUZ 2024
  • GNFT 2019
  • Fundamental
  • Price
  • GAUZ $6.64
  • GNFT $3.75
  • Analyst Decision
  • GAUZ Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • GAUZ 3
  • GNFT 1
  • Target Price
  • GAUZ $14.67
  • GNFT $13.00
  • AVG Volume (30 Days)
  • GAUZ 460.6K
  • GNFT 3.8K
  • Earning Date
  • GAUZ 08-07-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • GAUZ N/A
  • GNFT N/A
  • EPS Growth
  • GAUZ N/A
  • GNFT N/A
  • EPS
  • GAUZ N/A
  • GNFT 0.03
  • Revenue
  • GAUZ $101,165,000.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • GAUZ $28.49
  • GNFT $15.98
  • Revenue Next Year
  • GAUZ $47.77
  • GNFT N/A
  • P/E Ratio
  • GAUZ N/A
  • GNFT $120.71
  • Revenue Growth
  • GAUZ 18.63
  • GNFT 105.01
  • 52 Week Low
  • GAUZ $5.50
  • GNFT $2.55
  • 52 Week High
  • GAUZ $13.00
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • GNFT 44.52
  • Support Level
  • GAUZ N/A
  • GNFT $3.44
  • Resistance Level
  • GAUZ N/A
  • GNFT $3.81
  • Average True Range (ATR)
  • GAUZ 0.00
  • GNFT 0.17
  • MACD
  • GAUZ 0.00
  • GNFT -0.00
  • Stochastic Oscillator
  • GAUZ 0.00
  • GNFT 56.65

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: